Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes
| Status: | Completed |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/23/2016 |
| Start Date: | April 2000 |
| End Date: | December 2003 |
Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Basal/Bolus Therapy for Patients With Gestational Diabetes
This trial is conducted in the United States of America (USA). The purpose of this study is
to test whether NovoLog (insulin aspart) is a safe and at least as effective alternative to
regular human insulin for the control of blood glucose after meals in women who develop
diabetes during pregnancy.
to test whether NovoLog (insulin aspart) is a safe and at least as effective alternative to
regular human insulin for the control of blood glucose after meals in women who develop
diabetes during pregnancy.
Inclusion Criteria:
- Subjects older than 35 years old will be considered
- Gestational diabetes mellitus
We found this trial at
1
site
Click here to add this to my saved trials
